Molecular mechanisms and sites of action of the gelatinases in autoimmune CNS inflamma-tion: do MMP-2/-9 contribute to meningeal inflammation and secondary cortical damage?

B03

Meningeal inflammation results in cortical damage and correlates with disability in MS, but is poorly understood. We showed that gelatinases (matrix metalloproteinase (MMP)-2 and -9) control leuko-cyte penetration of the blood-brain barrier at postcapillary venules and propose that they serve simi-lar functions at the meningeal-brain border. We will investigate gelatinases in the meninges of MS patients and mouse experimental atoimmune encephalomyelitis (EAE), identify novel gelatinase substrates that induce meningeal inflammation, and test these substrates in patients. Meningeal T cells will be tracked in mice lacking MMP-2/-9. By understanding meningeal inflammation, we aim to understand drivers of disability in MS. Our project is guided by these questions:

    1. What is the difference between the meninges of MS patients and healthy controls? This question will be answered based on an unbiased cellular map of the meninges in human MS which will be compared with cortical pathology.
    2. Whereare gelatinases expressed? H how do they contribute to inflammation in the meninges?
    3. Which gelatinase substrates mediate meningeal inflammation induced by Th17 cells? Can they be traced in cerebrospinal fluid?
    4. Do gelatinases affect meningeal T cell trafficking in vivo?

B03

MMP-2/-9 actvity at sites of leukocyte penetration of the CNS parenchyma
in postcapillary venules and meninges

 

Principal Investigators:
Univ.-Prof. Dr. rer. nat. Lydia Sorokin
Institut für Physiologische Chemie und Pathobiochemie
Münster
sorokin@uni-muenster.de

Priv.-Doz. Dr. med. Gerd Meyer zu Hörste
Klinik für Neurologie mit Institut für Translationale Neurologie
Münster
gerd.meyerzuhoerste@ukmuenster.de

News

Thu, 15/09/2022
Photo gallery: Inflammation & Imaging Symposium in the MIC building
Muenster. From September 12th to 14th scientists from Muenster University and their international guests discussed the latest developments in research on inflammation and the imaging of the immune system at the 2nd Inflammation & Imaging Symposium. The annual event is jointly organised by several research networks from Münster, among them the CRC/TRR 128 “Multiple Sclerosis”. […]...more
Tue, 28/06/2022
CRC Retreat in Münster
Muenster. After a long pause, more than 90 participants of the CRC joined in Muenster Factory Hotel to update on the latest developments. We heard the most recent on a selection of the CRC projects and there was also plenty of time for fruitful discussion and socializing in the evening....more
Mon, 23/05/2022
EU Research Council awards Lydia Sorokin Advanced Grant
Münster – The biochemist and Principal investigator of the CRC 128 Prof. Dr. Lydia Sorokin has received the coveted “Advanced Grant” awarded by the European Research Council (ERC). The funding of ca. 2.3 million euros enables the realisation of outstanding research projects. Lydia Sorokin heads the Institute for Physiological Chemistry and Pathobiochemistry at Muenster University. […]...more